Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David DeMets

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Clinical Trials (London, England)|May 10, 2018
The independent statistician model: How well is it working?David DeMets
IRB|April 1, 1981
The data monitoring committee: how it operates and whyLawrence Friedman, David DeMets
JAMA|March 17, 2011
Statistical association and causation: contributions of different types of evidenceCharles H Hennekens, David DeMets
JAMA|December 3, 2009
The need for large-scale randomized evidence without undue emphasis on small trials, meta-analyses, or subgroup analysesCharles H Hennekens, David Demets
Therapeutic Innovation & Regulatory Science|September 25, 2023
Training New DMC Members: A Call to ActionFrank Rockhold, Kenneth Mahaffey, David DeMets
Clinical Trials (London, England)|October 17, 2013
University of Pennsylvania 5th annual conference on statistical issues in clinical trials: emerging statistical issues in biomarker validation (Morning Session)David DeMets, Janet Wittes, Jay Siegel
Circulation|August 3, 2005
Cyclooxygenase inhibition and cardiovascular riskElliott M Antman, David DeMets, Joseph Loscalzo
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|August 1, 2015
Type 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirementsFred Yang, Murray Stewart, June Ye, et al.
Journal of the American College of Cardiology|June 1, 2019
Monitoring Emerging Data From the COMPASS Trial of an Antithrombotic AgentJohn A Cairns, John W Eikelboom, Olga Shestakovska, et al.
Statistics in Medicine|July 19, 2012
The future of clinical trials: A panel discussionRalph D'Agostino, David DeMets, William Friedewald, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Clinical Trials (London, England)|May 10, 2018
The independent statistician model: How well is it working?David DeMets
IRB|April 1, 1981
The data monitoring committee: how it operates and whyLawrence Friedman, David DeMets
JAMA|March 17, 2011
Statistical association and causation: contributions of different types of evidenceCharles H Hennekens, David DeMets
JAMA|December 3, 2009
The need for large-scale randomized evidence without undue emphasis on small trials, meta-analyses, or subgroup analysesCharles H Hennekens, David Demets
Therapeutic Innovation & Regulatory Science|September 25, 2023
Training New DMC Members: A Call to ActionFrank Rockhold, Kenneth Mahaffey, David DeMets
Clinical Trials (London, England)|October 17, 2013
University of Pennsylvania 5th annual conference on statistical issues in clinical trials: emerging statistical issues in biomarker validation (Morning Session)David DeMets, Janet Wittes, Jay Siegel
Circulation|August 3, 2005
Cyclooxygenase inhibition and cardiovascular riskElliott M Antman, David DeMets, Joseph Loscalzo
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|August 1, 2015
Type 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirementsFred Yang, Murray Stewart, June Ye, et al.
Journal of the American College of Cardiology|June 1, 2019
Monitoring Emerging Data From the COMPASS Trial of an Antithrombotic AgentJohn A Cairns, John W Eikelboom, Olga Shestakovska, et al.
Statistics in Medicine|July 19, 2012
The future of clinical trials: A panel discussionRalph D'Agostino, David DeMets, William Friedewald, et al.
Pageof 6